Saliva‐derived cfDNA is applicable for EGFR mutation detection but not for quantitation analysis in non‐small cell lung cancer

Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology

(2019) Giovanni Ponti et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma

(2018) Chiara Gai et al.   BMC CANCER

Adapting an Established Clinical Chemistry Quality Control Measure for Droplet Generation Performance in Digital PCR

(2018) Su Kah Goh et al.   CLINICAL CHEMISTRY

Clinical Value of Naa10p and CEA Levels in Saliva and Serum for Diagnosis of Oral Squamous Cell Carcinoma

(2018) Jun Zheng et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Circulating tumor DNA measurement provides reliable mutation detection in mice with human lung cancer xenografts

(2018) Ling Wei et al.   LABORATORY INVESTIGATION

Human salivary microRNAs in Cancer

(2018) Óscar Rapado-González et al.   Journal of Cancer

Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer

(2018) Feng Li et al.   CLINICAL CHEMISTRY

Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR

(2017) Qian Zeng et al.   Molecular Diagnosis & Therapy

Cell-free DNA: Treasure trove for cancer medicine

(2017) Miljana Tanić et al.   NATURE MATERIALS

Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients

(2017) Yunxia Wan et al.   Oncotarget

Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer

(2017) Myung Han Hyun et al.   Oncotarget

Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker

(2016) Daniel Pietrasz et al.   CLINICAL CANCER RESEARCH

Plasma and saliva miR-21 expression in colorectal cancer patients

(2016) A. A. Sazanov et al.   JOURNAL OF APPLIED GENETICS

Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer

(2016) Xingguo Song et al.   Scientific Reports

Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study

(2016) Dan Pu et al.   Thoracic Cancer

Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease

(2015) A Szpechcinski et al.   BRITISH JOURNAL OF CANCER

Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell Lung Cancer

(2015) Guanshan Zhu et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Noninvasive Saliva-basedEGFRGene Mutation Detection in Patients with Lung Cancer

(2014) Fang Wei et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

High Sensitivity Detection and Quantitation of DNA Copy Number and Single Nucleotide Variants with Single Color Droplet Digital PCR

(2014) Laura Miotke et al.   ANALYTICAL CHEMISTRY

Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

(2014) Dharanija Madhavan et al.   BREAST CANCER RESEARCH AND TREATMENT

Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer

(2014) Kun Nie et al.   TUMOR BIOLOGY

Saliva Supernatant miR-21: a Novel Potential Biomarker for Esophageal Cancer Detection

(2013) Zi-Jun Xie et al.   Asian Pacific Journal of Cancer Prevention

Salivary Biomarkers: Toward Future Clinical and Diagnostic Utilities

(2013) J. M. Yoshizawa et al.   CLINICAL MICROBIOLOGY REVIEWS

Levels of cell-free DNA and plasma KRAS during treatment of advanced NSCLC

(2013) ANNELI DOWLER NYGAARD et al.   ONCOLOGY REPORTS

Multiple Marker Detection in Peripheral Blood for NSCLC Diagnosis

(2013) Paola Ulivi et al.   PLoS One

Saliva collection methods for DNA biomarker analysis in oral cancer patients

(2012) April M. Matthews et al.   BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY

Quantitative analysis of free-circulating DNA in plasma of patients with resectable NSCLC

(2012) Adam Szpechcinski et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Influence of Chemotherapy onEGFRMutation Status Among Patients With Non–Small-Cell Lung Cancer

(2012) Hua Bai et al.   JOURNAL OF CLINICAL ONCOLOGY

Genotyping Performance between Saliva and Blood-Derived Genomic DNAs on the DMET Array: A Comparison

(2012) Yueshan Hu et al.   PLoS One

Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients

(2012) Raquel Catarino et al.   PLoS One

Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy

(2011) Y. J. Lee et al.   CLINICAL CANCER RESEARCH

Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer

(2011) Rafael Sirera et al.   Journal of Thoracic Oncology

Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies

(2010) M. Bahlo et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection

(2009) N. J. Park et al.   CLINICAL CANCER RESEARCH

To spear or not to spear: Comparison of saliva collection methods

(2008) Bonny Donzella et al.   DEVELOPMENTAL PSYCHOBIOLOGY